Role of serotonin(2C) receptors in the control of brain dopaminergic function (Q34558814)

3 August 2017

1 reference

title

Role of serotonin(2C) receptors in the control of brain dopaminergic function (English)

1 reference

3 August 2017

1 reference

2

Marisa Cacchio

1 reference

3 August 2017

Vincenzo Di Matteo

1

1 reference

3 August 2017

Camillo Di Giulio

series ordinal

3

1 reference

3 August 2017

Ennio Esposito

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Pharmacology, Biochemistry and Behavior

3 August 2017

1 reference

3 August 2017

71

1 reference

3 August 2017

727-734

1 reference

3 August 2017

4

1 reference

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Levodopa: is toxicity a myth?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

A review of central 5-HT receptors and their function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

5-HT2 receptor subtypes: a family re-united?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Molecular biology of 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Dopamine and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin 2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Parkinson's disease: prospects for improved drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Brain 5-HT1C receptors and antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Reversal of antidepressant action by dopamine antagonists in an animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

An investigation of the role of 5-HT(2C) receptors in modifying ethanol self-administration behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900705-5

7 January 2021

10.1016/S0091-3057(01)00705-5

Identifiers

DOI

1 reference

3 August 2017

1 reference